NCT06761066View on ClinicalTrials.gov

Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Alzheimer Disease
Interventions
DIETARY_SUPPLEMENT

NVP-NK4146

BID for 36 weeks orally

DIETARY_SUPPLEMENT

NVP-NK4146 Placebo

BID for 36 weeks orally

Sponsors

Lead Sponsor

NVP Healthcare
All Listed Sponsors
lead

NVP Healthcare

INDUSTRY